ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RARE Ultragenyx Pharmaceutical Inc

48.24
-0.47 (-0.96%)
Last Updated: 17:07:06
Delayed by 15 minutes

Ultragenyx Pharmaceutical Financial Summary

The current RARE market cap is 4.45B. The company's latest EPS is USD -6.5693 and P/E is -7.39.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 98.05M127.39M108.83M147.03M139.49M
Operating Income -145.1M-122.05M-165.35M-116.36M-131.99M
Net Income -159.65M-123.19M-170.68M-131.6M-133.52M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 103.71M271.03M351.41M363.33M434.25M
Operating Income -424.17M-330.12M-381.74M-648.92M-569.21M
Net Income -402.73M-186.57M-454.03M-707.42M-606.64M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.24B1.49B1.31B1.62B1.54B
Total Liabilities 1.21B1.22B1.17B1.19B1.18B
Total Equity 31.71M275.41M140.26M432.42M346.83M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.14B1.76B1.52B1.55B1.49B
Total Liabilities 481.73M605.18M599.84M1.19B1.22B
Total Equity 653.76M1.15B922.56M352.49M275.41M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -390.9M-474.81M-190.73M-267.69M-334.69M
Investing 275.02M168M94.44M155M-120.5M
Financing 57.53M388.14M-58k384.88M396.06M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -345.38M-132.22M-338.71M-380.47M-474.81M
Investing -13.04M-179.12M-195.37M-291.65M168M
Financing 679.31M600.27M118.55M501.21M388.14M
Market Cap 4.45B
Price to Earnings Ratio -7.39
Price to Sales Ratio 10.32
Price to Cash Ratio 20.99
Price to Book Ratio 16.28
Dividend Yield -

Share Statistics

Shares Outstanding 92.34M
Average Volume (1 week) 992.36k
Average Volume (1 Month) 864.34k
52 Week Change 31.12%
52 Week High 60.37
52 Week Low 36.51
Spread (Intraday) 0.11 (0.23%)

Company Info

Company Name Ultragenyx Pharmaceutical Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.ultragenyx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock